Antigen - Publications - Faculty & Research

2024
Working Paper

Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances

In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details

Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms

Citation

SSRN

Read Now

May 2014 (Revised January 2015)
Case

Vaxess Technologies, Inc.

By: John A. Quelch and Margaret L. Rodriguez

In February 2014, Michael Schrader, chief executive of Vaxess Technologies, Inc., was assessing the startup health care company's 2014 marketing plan. On December 31st, 2013, Vaxess had obtained an exclusive license to a series of patents for a silk protein technology... View Details

Keywords: Vaccine; Cold Chain; Antigen; Temperature Controlled; Developing Markets; Immunization; Health Care and Treatment; Health Pandemics; Global Strategy; Supply Chain; Health; Health Industry; Medical Devices and Supplies Industry

Citation

Educators

Purchase

Web

Curriculum - MBA

bedside with an emphasis on translational research. Topics will include in vitro microbial discovery platforms; engineering strategies such as chimeric, humanized, and human Abs; human Fc engineering; and nanobodies, antibody drug conjugates, and immunotoxins and... View Details

Web

FAQs - Alumni

University Health Services are not able to provide monitored antigen or ad hoc PCR tests. Any individual in our community can always choose to wear a mask and should never feel obliged to explain the reasons for their decision. What... View Details

Publications